1. Home
  2. LEGN vs MTH Comparison

LEGN vs MTH Comparison

Compare LEGN & MTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • MTH
  • Stock Information
  • Founded
  • LEGN 2014
  • MTH 1985
  • Country
  • LEGN United States
  • MTH United States
  • Employees
  • LEGN N/A
  • MTH N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • MTH Homebuilding
  • Sector
  • LEGN Health Care
  • MTH Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • MTH Nasdaq
  • Market Cap
  • LEGN 5.9B
  • MTH 5.1B
  • IPO Year
  • LEGN 2020
  • MTH 1988
  • Fundamental
  • Price
  • LEGN $29.60
  • MTH $65.91
  • Analyst Decision
  • LEGN Strong Buy
  • MTH Buy
  • Analyst Count
  • LEGN 13
  • MTH 8
  • Target Price
  • LEGN $72.92
  • MTH $82.88
  • AVG Volume (30 Days)
  • LEGN 1.3M
  • MTH 921.5K
  • Earning Date
  • LEGN 11-12-2025
  • MTH 10-28-2025
  • Dividend Yield
  • LEGN N/A
  • MTH 2.62%
  • EPS Growth
  • LEGN N/A
  • MTH N/A
  • EPS
  • LEGN N/A
  • MTH 7.50
  • Revenue
  • LEGN $909,045,000.00
  • MTH $6,043,594,000.00
  • Revenue This Year
  • LEGN $68.68
  • MTH N/A
  • Revenue Next Year
  • LEGN $48.49
  • MTH $6.42
  • P/E Ratio
  • LEGN N/A
  • MTH $8.76
  • Revenue Growth
  • LEGN 74.75
  • MTH N/A
  • 52 Week Low
  • LEGN $27.34
  • MTH $59.27
  • 52 Week High
  • LEGN $45.30
  • MTH $98.74
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 30.03
  • MTH 41.53
  • Support Level
  • LEGN $29.92
  • MTH $64.99
  • Resistance Level
  • LEGN $33.50
  • MTH $69.66
  • Average True Range (ATR)
  • LEGN 1.31
  • MTH 1.92
  • MACD
  • LEGN -0.21
  • MTH -0.00
  • Stochastic Oscillator
  • LEGN 7.78
  • MTH 37.83

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

Share on Social Networks: